Delivery Order SPE2DB22D1106-SPE2DB25FDSH4
Award Date
12/30/24
Potential Completion Date
12/31/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,909.85 firm fixed-price delivery order is for the supply of 4565897017 - NALBUPHINE 100 MG/10 ML VIAL 10ML, with a period of performance through September 23, 2024. This contract is not associated with any set-aside requirements.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $2,737.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of 4562194143 - NALBUPHINE 200 MG/10 ML VIAL 10ML, with a completion date of September 18, 2023. The contract type is Firm Fixed Price.
Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award to Amerisourcebergen Drug Corp (AmerisourceBergen) was issued by the Defense Logistics Agency (DLA) as a delivery order under a larger Indefinite Delivery Contract (IDC). The award, valued at $3,498.93, is for the supply of NALBUPHINE 100 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has a period of performance through December 20, 2024 and utilizes a Firm Fixed Price pricing structure. The award was not designated under any set-aside program. As a...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office division, involves the delivery of NALBUPHINE 200 MG/10 ML VIAL 10ML pharmaceutical products. The award, valued at $4,561.80, was made by the Defense Logistics Agency (DLA) on August 14, 2024, with a completion date of August 15, 2024. This is a Firm Fixed Price Delivery Order contract, and there is no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,033.60, is for the delivery of a range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical care materials.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $2,245.32, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $11,193.44, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to supply a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,101.60, is a delivery order for pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical medical commodities.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $1,069.52, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp was issued by the Defense Logistics Agency (DLA) Troop Support Medical. It is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide.
The specific award is for 4,565,477,002 units of Bupivacaine 0.5% Vial...